SHL Telemedicine Ltd. Unsponsored ADR (SHLT)
(Delayed Data from NSDQ)
$2.93 USD
+0.17 (6.16%)
Updated Oct 11, 2024 01:54 PM ET
After-Market: $3.20 +0.27 (9.21%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
SHL Telemedicine Ltd. Unsponsored ADR (SHLT) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$11.00 | $11.00 | $11.00 | 298.55% |
Price Target
Only one analyst offered a short-term price target of $11.00 for SHL Telemedicine Ltd. Unsponsored ADR. This represents an increase of 298.55% from the last closing price of $2.76.
Analyst Price Targets (1 )
Broker Rating
Only one brokerage firm provided a Strong Buy-equivalent recommendation for SHL Telemedicine Ltd. Unsponsored ADR. This translates to an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell). ABR is the calculated average of actual recommendations (Buy, Hold, Sell etc.) made by brokerage firms.
The current ABR compares to an ABR of 1.00 a month ago based on just one Strong Buy recommendation.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
3/14/2024 | Litchfield Hills Research | Theodore R O'Neill | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 1 |
Average Target Price | $11.00 |
LT Growth Rate | NA |
Industry | Medical Info Systems |
Industry Rank by ABR | 71 of 252 |
Current Quarter EPS Est: | NA |
SHLT FAQs
SHL Telemedicine Ltd. Unsponsored ADR (SHLT) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 1 brokerage firms.
The average price target for SHL Telemedicine Ltd. Unsponsored ADR (SHLT) is $11.00. The current on short-term price targets is based on 1 reports.
The forecasts for SHL Telemedicine Ltd. Unsponsored ADR (SHLT) range from a low of $11 to a high of $11. The average price target represents a increase of $275.43 from the last closing price of $2.93.
The current UPSIDE for SHL Telemedicine Ltd. Unsponsored ADR (SHLT) is 275.43%
Only one analyst offered a short-term price target of $11.00 for SHL Telemedicine Ltd. Unsponsored ADR. This represents an increase of 298.55% from the last closing price of $2.76.